Skip to content

US · 21 CFR

21 CFR Part 606

Current Good Manufacturing Practice for Blood and Blood Components

eCFR, up to date as of 2026-11-12

Table of contents

  1. 606.3Definitions.
  2. 606.20Personnel.
  3. 606.40Facilities.
  4. 606.60Equipment.
  5. 606.65Supplies and reagents.
  6. 606.100Standard operating procedures.
  7. 606.110Plateletpheresis, leukapheresis, and plasmapheresis.
  8. 606.120Labeling, general requirements.
  9. 606.121Container label.
  10. 606.122Circular of information.
  11. 606.140Laboratory controls.
  12. 606.145Control of bacterial contamination of platelets.
  13. 606.151Compatibility testing.
  14. 606.160Records.
  15. 606.165Distribution and receipt; procedures and records.
  16. 606.170Adverse reaction file.
  17. 606.171Reporting of product deviations by licensed manufacturers, unlicensed registered blood establishments, and transfusion services.
Cover page and contents (original)

Authority:21 U.S.C. 321, 331, 351, 352, 355, 360, 360j, 371, 374; 42 U.S.C. 216, 262, 263a, 264.

Source:40 FR 53532, Nov. 18, 1975, unless otherwise noted.

Source: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · retrieved 2026-11-16

Weekly Newsletter

Get the week's FDA, EU and MFDS inspection findings

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Confirm by email to start · Unsubscribe any time